arXiv:2606. 26205v1 Announce Type: new Abstract: Patients increasingly seek medication information online, yet safety knowledge for psychiatric drugs is split between regulatory adverse-event records, which are authoritative but abstract, and patient narratives, which are experience-near but unvalidated.
By Huizi Yu, Jian Liu, Wenkong Wang, Lingyao Li, Jiayan Zhou, Zhaoqian Xue, Xiang Li, Xinxin Lin, Zhiying Liang, Zhuoru Wu, Siyuan Ma, Xin Ma, Lizhou Fan
arXiv:2509. 02594v3 Announce Type: replace-cross Abstract: Evaluating large language models (LLMs) on their ability to generate high-quality, accurate, situationally aware answers to clinical questions requires going beyond conventional benchmarks to assess how these systems behave in complex, high-stakes clinical scenarios.
By Sandhanakrishnan Ravichandran, Shivesh Kumar, Rogerio Corga Da Silva, Miguel Romano, Reinhard Berkels, Michiel van der Heijden, Olivier Fail, Valentine Emmanuel Gnanapragasam
The paper surveys open, non‑proprietary large language models (LLMs) and AI foundation models (AIFMs) for clinical use, presenting a taxonomy of current state‑of‑the‑art models. It empirically tests open‑weight LLMs on a personalized‑prescription task, finding that they match or surpass a proprietary baseline in overall suitability accuracy, especially when combined with Retrieval‑Augmented Generation (RAG). A subjective evaluation by blinded raters shows mixed effects of RAG on perceived suitability across multiple dimensions, and the authors discuss ethical risks and the need for responsible deployment.
By Mahdi Alkaeed, Sofiat Abioye, Adnan Qayyum, Yosra Magdi Mekki, Ilhem Berrou, Mohamed Abdallah, Ala Al-Fuqaha, Muhammad Bilal, Junaid Qadir
arXiv:2608. 09443v1 Announce Type: new Abstract: Large language model (LLM) agents can support medication review between clinical visits, but safe choices for older adults with multimorbidity depend on conditions, medications, and geriatric risks that users may omit.
By Zihan Wang, Anglin Liu, Rongyi Wang, Dantong Li, Yi Lu, Siqing Yuan, Hongxia Xu, Zhongtian Long, Jintai Chen
arXiv:2606. 15931v1 Announce Type: cross Abstract: Historical medical archives and traditional medicines hold immense potential for drug discovery and remain a primary source for current drug development.
By Zijian Carl Ma, Sean J. Wang, Sijbren Kramer, Li Erran Li
arXiv:2608. 03028v1 Announce Type: new Abstract: Applying a valid medication-safety rule when its patient-specific conditions are not met can produce an incorrect decision.
By Zhitian Hou, Yuhang Liu, Pengkai Wang, Zeyu Liu, Guanghao Zhu, Zheng Liu, Shuo Cai, Congkai Xie, Zhijie Sang, Kun Zeng, Hongxia Yang
arXiv:2610.14474v1 Announce Type: cross
Abstract: Medication recommendations seek to deliver personalized drug combinations based on patients' clinical information, where ensuring transparent decisio...
By Cong Wang, Jin Li, Shoujin Wang, Yishuo Li, Huilin Gu, Wenpeng Lu
arXiv:2610.33279v1 Announce Type: new
Abstract: Introduction: Increasing volumes of individual case safety reports (ICSRs) challenge expert-led causality assessment in pharmacovigilance. We developed...
By Daisy Rae Lopez, Angela Boccia, Maurizio Sessa
The paper introduces BAR, a Budget‑Aware LLM Reasoning framework that enhances post‑discharge risk prediction by integrating external medical knowledge graphs (KGs). BAR refines KGs into disease‑specific evidence graphs with support scores and provenance, then uses an LLM to plan, navigate, and verify evidence within a patient‑specific budget. Experiments on MIMIC‑III and MIMIC‑IV across eight diseases show BAR improves AUPRC by 3.4 points, raises citation precision from 59.8% to 77.9%, and uses only 62‑65% of the allotted budget.
By Chen Chen, Dongjie Wang, Mei Liu, Zijun Yao
arXiv:2603.17356v3 Announce Type: replace
Abstract: Drug recommendation requires a deep understanding of individual patient context, especially for complex conditions like Parkinson's disease. While...
By Chaeyoung Huh, Hyunmin Hwang, Jung Hwan Shin, Sungyang Jo, Jinse Park, Jong Chul Ye
arXiv:2606. 28692v1 Announce Type: new Abstract: Treatment reasoning underpins every therapeutic decision, integrating disease context, comorbidities, medications, contraindications, and evolving biomedical knowledge to select an appropriate therapy.
By Shanghua Gao, Ayush Noori, Richard Zhu, Curtis Ginder, Zhenglun Kong, Xiaorui Su, Justin Kauffman, Benjamin S. Glicksberg, Joshua Lampert, Ankit Sakhuja, Ashwin Sawant, ATHENA-R1 Evaluation Consortium, David A. Clifton, Noa Dagan, Ran Balicer, Marinka Zitnik
The study presents a dual large language model (LLM) consensus pipeline that extracts 18 trofinetide treatment-response phenotypes from clinical notes of 108 Rett syndrome patients. Using 26,763 notes, the pipeline achieved high accuracy (84.2% for diarrhea) and 90.2% agreement with expert reviewers across phenotypes. It demonstrates that in-context LLM reasoning can scale real‑world monitoring of treatment effects beyond traditional keyword or regex methods.
By Daniel Palacios, Guantong Qi, Mikael Guzman Karlsson, Shawntel K. David, Mohammed Sameeruddin, Bernhard Suter, Zhandong Liu, Davut Pehlivan, Hu Chen